Administration of Recombinant Interleukin 12 Prevents Outgrowth of Tumor Cells Metastasizing Spontaneously to Lung and Lymph Nodes

Cancer Research

Volumn 55, Issue 19, 1995, Pages 4404-4408

  Kobayashi, Michiko ^b   Herrmann, Steven ^b   Yamamoto, Norihiko ^a   Tsutsui, Tateki ^a   Tai, Xu Guang ^a   Fujiwara, Hiromi ^a   Hamaoka, Toshiyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER REGRESSION; CANCER TRANSPLANTATION; CONTROLLED STUDY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG METASTASIS; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL;

ANIMAL; ANTINEOPLASTIC AGENTS; FEMALE; INTERLEUKIN-12; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T;

EID: 0029090220     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B., and Trinchieri, G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J. Exp. Med., 170: 827–845, 1989.
2. Wolf, S. F., Temple, P. A., Kobayashi, M., Young, D., Dicig, M., Lowe, L., Dzialo, R., Fitz, L., Ferenz, C., Hewick, R. M., Kelleher, K., Herrmann, S. H., Clark, S. C., Azzoni, L., Chan, S. H., Trinchieri, G., and Perussia, B. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol., 146: 3074–3081, 1991.
3. Stern, A. S., Podiaski, F. J., Hulmes, J. D., Pan, Y.-C.E., Quinn, P. M., Wolitzky, A. G., Familletti, P. C., Stremlo, D. L., Train, T., Chizzonite, R., and Gately, M. K. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA, 87: 6808–6812, 1990.
4. Gubler, U., Chua, A. O., Schoenhaut, D. S., Dwyer, C. M., McComas, W., Motyka, R., Nabavi, N., Wolitzky, A. G., Quinn, P. M., Familletti, P. C., and Gately, M. K. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA, 88: 4143–4147, 1991.
5. Robertson, M. J., Soiffer, R. J., Wolf, S. F., Manley, T. J., Donahue, C., Young, D., Herrmann, S. H., and Ritz, J. Responses of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med., 175: 779–788, 1992.
6. Gately, M. K., Wolitzky, A. G., Quinn, P. M., and Chizzonite, R. Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell. Immunol., 143: 127–142, 1992.
7. Gately, M. K., Desai, B. B., Wolitzky, A. G., Quinn, P. M., Dwyer, C. M., Podiaski, F. J., Familletti, P. C., Sinigaglia, F., Chizonnite, R., Gubler, U., and Stern, A. S. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol., 147: 874–882, 1991.
8. Perussia, B., Chan, S. H., D'Andrea, A., Tsuji, K., Santoli, D., Pospisil, M., Young, D., Wolf, S. F., and Trinchieri, G. Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-a 06, TCR-yS+ T lymphocytes and NK cells. J. Immunol., 149: 3495–3502, 1992.
9. Chan, S. H., Perussia, B., Gupta, J. W., Kobayashi, M., Pospisil, M., Young, H. A., Wolf, S. F., Young, D., Clark, S. C., and Trinchieri, G. Induction of interferon 7 production by natural killer cell stimulatory factor: characterization of the responding cells and synergy with other inducers. J. Exp. Med., 173: 869–879, 1991.
10. Manetti, R., Parronchi, P., Giudizi, M. G., Piccinni, M. P., Maggi, E., Trinchieri, G., and Romagnani, S. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Thl)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med., 777: 1199–1204, 1993.
11. Trinchieri, G. Interleukin-12 and its role in the generation of TH1 cells. Immunol. Today, 14: 335–337, 1993.
12. Brunda, M. J., Luistro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F., and Gately, M. K. Antitumor and antimetastatic activity of interleukin-12 against murine tumors. J. Exp. Med., 178: 1223–1230, 1993.
13. Nastala, C. L., Edington, H. D., McKinney, T. G., Tahara, H., Nalesnik, M. A., Brunda, M. J., Gately, M. K., Wolf, S. F., Schreiber, R. D., Storkus, W. J., and Lotze, M. T. Recombinant IL-12 administration induces tumor regression in association with IFN-7 production. J. Immunol., 153: 1697–1706, 1994.
14. Tada, T., Ohzeki, S., Utsumi, K., Takiuchi, H., Muramatsu, M., Li, X.-F., Shimizu, J., Fujiwara, H., and Hamaoka, T. Transforming growth factor-0-induced inhibition of T cell function: susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. J. Immunol., 146: 1077–1082, 1991.
15. Li, X.-F., Takiuchi, H., Zou, J.-P., Katagiri, T., Yamamoto, N., Nagata, T., Ono, S., Fujiwara, H., and Hamaoka. T. Transforming growth factor-0 (TGF-0)-mediated immunosuppression in the tumor-bearing state: enhanced production of TGF-0 and a progressive increase in TGF-0 susceptibility of anti-tumor CD4+ T cell function. Jpn. J. Cancer Res., 84: 315–325, 1993.
16. Yamamoto, N., Zou, J.-P., Li, X.-F., Takenaka, H., Noda, S., Fujii, T., Ono, S., Kobayashi, Y., Mukaida, N., Matsushima, K., Fujiwara, H., and Hamaoka, T. Regulatory mechanisms for production of interferon y and tumor necrosis factor induced as anti-tumor immune responses in the tumor-bearing state. J. Immunol., 154: 2281–2290, 1995.
17. Hashimoto, M., Niwa, O., Nitta, Y., Takeichi M., and Yokora, K. Unstable expression of E-cadherin adhesion molecules in metastatic ovarian tumor cells. Jpn. J. Cancer Res., 80: 459–463, 1989.
18. Ogata, M., Shimizu, J., Kosaka, H., Maekawa, R., Shimizu, K., Fujiwara, H., and Hamaoka, T. Expression of H-2 antigens and inducibility of anti-tumor immune responses in various tumor cell clones established from methylcholanthrene-induced fibrosarcoma. Jpn. J. Cancer Res., 77: 1134–1141, 1986.
19. Zou, J.-P., Yamamoto, N., Fujii, T., Takenaka, H., Kobayashi, M., Herrmann, S. H., Wolf, S. F., Fujiwara, H., and Hamaoka, T. Systemic administration of rIL-12 response is correlated with a striking reversal of suppressed interferon-y production by anti-tumor T cells. Int. Immunol., 7: 1135–1145, 1995.
20. Hellstrom, K. E., and Hellstrom, I. Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv. Immunol., 18: 209–277, 1974.
21. Kirchner, H., Chused, T. M., Herberman, R. B., Holden, H. T., and Lavrin, D. H. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus. J. Exp. Med., 139: 1473–1487, 1974.
22. Treves, A. J., Caroaud, C., Trainin, N., Feldman, M., and Cohen, I. R. Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor. Eur. J. Immunol., 4: 722–727, 1974.
23. Kamo, I., and Friedman, H. Immunosuppression and the role of suppressive factors in cancer. Adv. Cancer Res., 25: 271–321, 1977.
24. Dye, E. S., and North, R. J. T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases. J. Exp. Med., 154: 1033–1042, 1981.
25. Fujii, T., Igarashi, T., and Kishimoto, S. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice. J. Natl. Cancer Inst., 78:509–517,1987.
26. Tada, T., Sano, H., Sato, S., Shima, J., Fujiwara, H., and Hamaoka, T. Immune dysfunction expressed selectively on L3T4+ T cells in the tumor-bearing state. J. Leukocyte Biol., 47: 149–154, 1990.
27. Zou, J.-P., Shimizu, J., Ikegame, K., Yamamoto, N., Ono, S., Fujiwara, H., and Hamaoka, T. Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity. J. Immunol., 148: 648–655, 1992.